NEW YORK, March 21, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Global Imaging Agents Industry
http://www.reportlinker.com/p0326398/Global-Imaging-Agents-Industry.html
This report analyzes the worldwide markets for Imaging Agents in US$ Million by the following product segments - Contrast Media (X-Ray, MRI, & Ultrasound), and Diagnostic Radiopharmaceuticals. The report provides separate comprehensive analytics for the US, Canada, Japan, Europe, Asia-Pacific, Middle East, and Latin America. Annual estimates and forecasts are provided for each region for the period 2007 through 2015. Also, a seven-year historic analysis is provided for these markets. The report profiles 55 companies including many key and niche players such as AMAG Pharmaceuticals Inc., Bayer Schering Pharma AG, Bracco Group, Covidien, Cytogen Corp., Daiichi Sankyo Company Limited, Eisai Co., Ltd, GE Healthcare, Guerbet Group, and Lantheus Medical Imaging. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources.
1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 1
Study Reliability and Reporting Limitations 1
Disclaimers 2
Data Interpretation & Reporting Level 3
Quantitative Techniques & Analytics 3
Product Definitions and Scope of Study 3
A. Contrast Media 3
X-Ray Contrast Media 3
Magnetic Resonance Imaging (MRI) Contrast Media 4
Ultrasound Contrast Media 4
B. Diagnostic Radiopharmaceuticals 4
2. INDUSTRY OVERVIEW 6
Medical Imaging Industry Under the Impact of Economic Downturn 6
Future Prospects 6
Targeted MRI Imaging - A Game Changer in the Making? 8
Developing Countries to Spur Growth 8
A Quick Primer On Imaging Agents 8
Growth Drivers 9
Growth Inhibitors 10
Changing Dynamics of Imaging Agents 11
Imaging Agents: Significant Growth Ahead 12
Rise of Non-Ionizing Imaging Techniques 12
Fusion Imaging Modalities: Greater Clinical Benefits 13
Radioactive Isotopes Utilized in PET & SPECT Imaging Procedures 13
Radiopharmaceuticals-An Exotic Tool 14
Nanomaterials Taking the Center Stage 14
Gadolinium Coated Nanoparticles- A Promising Imaging Agent 15
A Peek Into Pricing Dynamics 15
A Synoptic Overview 15
Pros & Cons 16
Positive Factors Driving Prices 16
Negative Factors Bearing Down on Prices 16
Reimbursements 17
"Under the Umbrella" 17
Europe 17
United States 17
3. MARKET TRENDS & ISSUES 19
Falling Prices Turn On the Heat 19
X-Ray Contrast Media: Declining Sector 19
MRI Contrast Media: Playing at Center Court 19
Impact Wielded by Ballooning MRI Practices 19
Ultrasound Contrast Media: A Rising Star in the Quadrant 20
Fledging Market Battles Teething Challenges 21
PET: A Prime Growth Driver for Radiopharmaceuticals 21
Nuclear Medicine: A Potential Growth Avenue for
Radiopharmaceuticals 22
Select Cardiology and Oncology Radiopharmaceuticals 22
4. COMPETITION 23
Market Structure 23
Big Guns in the Emerging MRI Market 24
Bayer Schering Pharma AG: A Pioneering Developer of MRI
Contrast Agents 24
Competitive Scenario 25
Table 1: Worldwide Imaging Agents Market (2009E): Percentage
Breakdown of Value Sales for Leading Players- GE Healthcare,
Bracco, Covidien, Bayer Schering Pharma, and Others (includes
corresponding Graph/Chart) 25
Table 2: X-ray Medical Contrast Media Market Worldwide
(2009E): Percentage Breakdown of Sales for GE Healthcare,
Bracco, Covidien, Bayer Schering Pharma and Others (includes
corresponding Graph/Chart) 25
Table 3: MRI Contrast Media Market Worldwide (2009):
Percentage Breakdown of Sales for Bayer Schering Pharma, GE
Healthcare, Bracco, Covidien and Others (includes
corresponding Graph/Chart) 26
Table 4: Radiopharmaceutical Contrast Media Market Worldwide:
Percentage Share of Leading Players for 2007 - GE Healthcare,
Bristol-Myers Squibb, Mallinckrodt/ Covidien, MDS Nordion and
Others (Revenue Share) (includes corresponding Graph/Chart) 26
5. TECHNOLOGY BREAKTHROUGHS 27
Molecular Imaging Agents: The Outer Limits 27
On Cards: Hyperpolarized Gases as Contrast Agents 27
Imaging Agents Make a Welcome Impact in the Field of
Alzheimer's Disease 28
Technetium-99m: A Breakthrough Contrast Agent for CNS Imaging 28
A New Imaging Agent for Radiopharmaceutical Scans 28
Multi-Modal Image Registration: Combating Contrast Medium
Inconsistencies 28
Saline Flushes To Help Ensure Accurate Delivery of Contrast
Agents 29
6. PRODUCT OVERVIEW 30
Contrast Agents 30
Contrast Media: How Do They Function? 30
Where Are They Used ? 31
Evolution of Contrast Media: A Profile 31
Bismuth Nitrate: Beginning of Contrast Agents 31
Imaging Agents: Significant Developments in the Last Fifty Years 32
Schering Develops First Intravenous Contrast Agent 32
MRI: Creating a New Era for Contrast Agents 32
A Peek into the Finer Points of Differences Among Contrast Media 32
Viscosity 32
Osmolality 33
Chemotoxicity 33
Second Generation Non-Ionic Contrast Agents: An Introduction 33
Choice of the Contrast Medium: A Weighty Decision 33
Factors affecting choice of Imaging Agents 33
Taxonomy 34
Types of Contrast Media 34
X-Ray Contrast Medium 34
First Generation High Osmolar Contrast Media 35
Second Generation Low Osmolar Contrast Media or LOCM 35
Table 5: Comparative Analysis of Structure of Non-ionic and
ionic X-ray Contrast Media 35
MRI Contrast Medium 35
Role of Contrast Enhancement in MR Angiography (MRA) 37
MRI Contrast Agents for the Liver 37
Paramagnetic extracellular contrast agents 37
Hepatobiliary Gadolinium Chelates 37
Superparamagnetic Iron Oxide Particles 37
Ultrasound Contrast Medium 37
Ultrasonographic Contrast Media: What Are They? 38
Ultrasound Contrast Enhancement in Cardiology 39
Functionalities of Vascular Ultrasound Contrast Agents 39
Diagnostic Radiopharmaceuticals 39
Key Radioactive Isotopes used as Diagnostic
Radiopharmaceuticals 40
A Delineate of Diagnostic Radiopharmaceuticals 41
Diagnostic Radiopharmaceuticals: A Technical Run-Through 41
Applications 42
7. A SEGMENTAL REVIEW 43
Contrast Media 43
Popular Brands of Contrast Agents 43
X-ray Contrast Media 44
Market Scenario 44
MRI Contrast Media 45
Market Scenario 44
Ultrasound Contrast Media 45
Market Overview 45
Competitive Scenario 46
Diagnostic Radiopharmaceuticals 46
Market Overview 46
Immunoconjugates 46
Market Overview 46
Competitive Scenario 47
8. TECHNOLOGY DYNAMICS 48
Proprietary Technologies Making Significant In-Roads 48
Advanced Magnetics' Proprietary Colloidal Superparamagnetic
Particle Technology 48
Enzon's Single Chain Antigen-Binding Technology 48
Immunomedics' Antibody Technology 48
First Generation 48
Second Generation 48
Third Generation 48
NeoRx's "Painting the Target" Technology 49
Stage - I 49
Stage - II 49
Stage - III 49
Gas Encapsulation Technology for Ultrasound Contrast Media 49
Pharmacyclics' Texaphyrin Technology 50
Regulatory Bodies 50
Ultrasound Contrast Agents Are Drugs, Not Devices - Rules US FDA 50
Entry Barriers 50
Research Driven Markets 50
Highly Competitive Market 51
Economies of Scale 51
Substitutes in Agents Manufacturing 51
New X-ray Diagnostic Agents 51
Amide-based Macrocyclic Ligands - Potential MRI Agents 51
Gadolinium (III) Complexes - Potential MRI Contrast Agents 51
Metal-Containing Compounds Act As Potential Contrast Agents 51
Therapeutic Applications 51
Diagnostic Applications 52
Magnetic Gels as Potential MRI Contrast Agents 52
PFCs as Diagnostic Contrast Agents 52
9. PRODUCT LAUNCHES 53
GE Healthcare Receives FDA Approval for DaTscan for detecting
Dopamine Transporters 53
Targeson Launches Targestar® P-HF 53
GE Healthcare Announces Phase II Study Results of
Flutemetamol, the PET Imaging Agent for Brain Imaging 53
GE Healthcare Receives FDA Approval for Cysview, An Optical
Imaging Agent for Cystoscopic Detection of Papillary Bladder
Cancer 53
INER Develops Imaging Agents for Cerebral Blood Flow 54
Lantheus Medical Imaging Introduces Definity Ultrasound
Contrast Imaging Agent in India 54
Sanochemia Pharmazeutika Completes DCP Phase of MRT Imaging
Agent, to Introduce Within Major European Markets by 2011 54
Bayer Transfers Liver MRI Contrast Medium Resovist Injection
to I'rom Pharmaceutical 54
GE Healthcare Re-Introduces Contrast Agent, OptisonTM 54
Lantheus Medical Imaging Introduces ABLAVAR™ in Canada 55
VisEn Introduces ProSense® 750 FAST and Neutrophil ElastaseTM
680 FAST 55
Bayer Works on Development of MR Contrast Agents for Breast
Cancer Diagnosis 55
Lantheus Medical Imaging Introduces ABLAVAR™ MRA Imaging Agent 56
VisEn Introduces Cat B 680 FAST™ Imaging Agent 56
VisEn Medical Introduces GastroSense 750 Fluorescence Imaging
Agent 56
VisEn Medical Unveils VivoTag® 645 Red Fluorescent Dye 57
VisEn Medical Launches VivoTag® 680 XL Fluorescent Dye 57
AMAG Pharmaceuticals Unveils Superparamagnetic Iron Oxide
Nanopaticles 57
MabCure Unveils Monoclonal Antibodies 57
VisEn Medical Introduces ReninSense680TM FAST 58
VisEn Medical Introduces New VivoTag® 800 and OsteoSense®
Imaging Agents 58
VisEn Medical Introduces Annexin-Vivo 750 Imaging Agent 58
VisEn Introduces New Fluorescence Molecular Imaging Agent,
IntegriSense™ 750 59
Bayer to Launch Primovist™ and Nexavar™ in Japan 59
Sanochemia Unveils MR-Lux® 60
VisEn Medical Introduces New Fluorescence in Vivo Imaging
Agent, IntegriSense 60
Bayer to Unleash Radiology Management System 61
Bayer to Unveil Pre-Filled Contrast-Medium Cartridges for MRI 61
10. RECENT INDUSTRY ACTIVITY 62
University of Montana Receives Patents for Two New Brain
Imaging Agents 62
Eli Lilly Acquires Avid Radiopharmaceuticals 62
GE Global Research Secures Multi-Year NIH Grant to Develop
Nerve Imaging Agent and Imaging System 62
Agfa Healthcare Snaps Insight Agents 62
Nordion to Divest MDS Nordion S.A. 63
Sofie Biosciences Secures Funds for Research on Molecular PET
Imaging Agents 63
Aposense Signs Collaboration Agreement With Roche 63
University of Washington to Collaborate with Cardinal Health
for Advancement of Molecular Imaging 63
ImaginAb Joins Hand with GE Imanet for Developmental Drug
Research 64
Cancer Targeted Technology Inks Agreement with Bayer Pharma
for Cancer PET Imaging Agent 64
Lantheus Medical Imaging Wins Global Rights for Gadofosveset
Trisodium 64
Avid Radiopharmaceuticals Partners with Siemens PETNET
Solutions for Production of Florbetapir F 18 64
VisEn Expands Fluorescence Imaging Intellectual Patent
Portfolio through Acquisition of Bayer Schering's Portfolio 65
Cardinal Health Enters into Partnership with ProVision for
Cyclotrons 65
Center for Diagnostic Imaging Sets up New Imaging Center 65
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL
Biologics 65
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement
for Molybdenum-99 66
Lantheus Medical Imaging Purchases MS-325 Related Rights from
EPIX Pharmaceuticals 66
GE Healthcare Inks Agreement with Nycomed 66
Photocure Secures Reimbursement Approval for Hexvix in Germany 66
Agfa HealthCare to Acquire Insight Agents 67
Eckert & Ziegler Disinvests FCI Contrast Media Business 67
Guerbet Signs Distribution Agreement with Draximage for its
Nuclear Medicine Product Range 68
ImaginAb Signs Sub Licensing Agreement for huJ591 with BZL
Biologics 68
Lantheus Medical Imaging and NTP Radioisotopes Sign Agreement
for Molybdenum-99 68
Lantheus Medical Imaging Purchases MS-325 Related Rights for
Select Markets from EPIX Pharmaceuticals 69
MDS Nordion, TRIUMF and University of British Columbia Enter
into Partnership 69
Alseres Pharmaceuticals Signs Agreement for Special Protocol
Assessment of Altropane 69
Pharmalucence Wins Approval from FDA for Sestamibi Kit 70
Covidien Obtains Approval from Health Canada for Sestamibi
Injection 70
MDS Nordion Commences Production of CardioGen-82 70
Avista Capital Partners Acquires Bristol-Myers Squibb Medical
Imaging 70
Amerinet Awards Contract to Bayer HealthCare 71
Bristol-Myers Squibb Medical Imaging Changes Name to Lantheus
Medical Imaging 71
Bayer Schering Secures FDA Marketing Clearance for Primovist® 72
Bracco-Eisai Secures Approval for Iomeron® 350 and Iomeron®
350 Syringe for Use in Dynamic Liver CT 72
Covidien Signs Co-Marketing Deal with PETNET over Nuclear
Medicine Therapies 73
EPIX Receives FDA Approval for Vasovist 74
GE Global and NCI Partner to Speed-up Development of Cancer
and Heart Disease Diagnosing Nanoparticle Imaging Agents 74
Lantheus Wins Contract from PPP 75
Sanguine to Take over Rockland 75
Starpharma Holdings Enters into an Agreement with Unilever 75
GE Healthcare and Cardinal Health Enter Into a Deal 75
Jubilant to Take Over DRAXIS 76
MTTI and Bexion to Partner for Nanovesicle 76
Otsuka Takes over IPP 76
Wilex Inks Deal with IBA 77
Cytogen Corporation to Merge Business with EUSA Pharma Inc 77
Bracco Group Acquires E-Z-EM 77
EPIX Pharmaceuticals to Resubmit New Drug Application (NDA)
for Vasovist 77
Bayer Schering, FutureChem Ink Licensing Deal 78
NuView Radio Pharmaceuticals Inks Agreement for Non- Invasive
Imaging Agent 78
11. CORPORATE ACTIVITY IN RECENT PAST - A PERSPECTIVE BUILDER 79
Advanced Magnetics Inc Changes Name to AMAG Pharmaceuticals 79
Bracco Diagnostics Inks Agreement with HealthTrust Purchasing
Group 79
Bracco Diagnostics Offers MRI Products to HealthTrust
Purchasing Group 79
Bayer HealthCare Offers MRI Contrast Agent to HealthTrust 79
Bayer HealthCare Extends Contract with Premier 79
Bayer HealthCare Sets Off US Operations 79
Tyco Healthcare Renamed to Covidien Ltd 80
Covidien Offers Imaging Solutions to MedAssets Supply Chain
Systems 80
Siemens, M.D. Anderson Cancer Center Set up Research Centre 80
Bayer, Berlex Merge Operations 80
AION Diagnostics Forays Pre-Clinical Imaging Agent Market 80
ART Acquires Alerion Biomedical 80
EPIX to Merge with Predix 81
Fujifilm Acquires Stake in Daiichi Radioisotope Laboratories 81
Bracco Diagnostics Inks Agreement with Amerinet 81
Vasovist receives Green Signal in Australia 81
AION Diagnostics Develops BioSilicon TM 81
Sonazoid Receives Import Approval 81
Schering AG Divests Radiopharmaceutical Business to Ion Beam
Applications and Institut National des Radioéléments 82
Vasovist Receives European Approval 82
Albany Molecular Research Renews Supply Agreement with GE
Healthcare 82
QuantRx Biomedical Corp. Acquires Stake in FluoroPharma 82
Palatin Technologies Withdraws NeutroSpec Imaging Agent 82
Diosynth Bags Contract to Produce Imaging Agent 83
GE Healthcare Signs Marketing Agreement with PhotoCure 83
DRAXIMAGE Receives the Green Signal in Europe 83
Daiichi and Sankyo Sign a Merger Deal 83
12. PRODUCT INTRODUCTIONS IN RECENT PAST - A PERSPECTIVE BUILDER 84
Insight Agents to Launch Generic Contrast Media Solutions In
Europe 84
Researchers Develop First Biocompatible MRI Contrast Agent 84
Signalomics and Invitrogen Collaborate to Develop Nanocrystal
Reagents 84
Schering AG Collaborates with Stanford University to Develop
Molecular Imaging Agent 84
Schering and Avid to Develop Diagnostic Imaging Agents 84
US National Institutes of Health Develops two PET Imaging Agents 85
13. FOCUS ON SELECT PLAYERS 86
AMAG Pharmaceuticals, Inc. (USA) 86
Bayer Schering Pharma AG (Germany) 86
Bracco Group (Italy) 86
Covidien (USA) 87
Cytogen Corp. (USA) 87
Daiichi Sankyo Company Limited (Japan) 88
Eisai Co Ltd. (Japan) 88
GE Healthcare (UK) 88
Guerbet Group (France) 89
Lantheus Medical Imaging (USA) 89
14. GLOBAL MARKET PERSPECTIVE 90
Table 6: World Recent Past, Current & Future Analysis for
Imaging Agents by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 90
Table 7: World Historic Review for Imaging Agents by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 91
Table 8: World 11-Year Perspective for Imaging Agents by
Geographic Region- Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 92
Table 9: World Recent Past, Current & Future Analysis for
Contrast Media by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 93
Table 10: World Historic Review for Contrast Media by
Geographic Region - US, Canada, Japan, Europe, Asia- Pacific
(excluding Japan), Middle East and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 94
Table 11: World 11-Year Perspective for Contrast Media by
Geographic Region- Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 95
Table 12: World Recent Past, Current & Future Analysis for
Contrast Media by Product Segments - X-Ray, MRI and Ultrasound
Markets Independently Analyzed with Annual Sales Figures in
US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 96
Table 13: World Historic Review for Contrast Media by Product
Segments - X-Ray, MRI and Ultrasound Markets Independently
Analyzed with Annual Sales Figures in US$ Million for Years
2000 through 2006 (includes corresponding Graph/Chart) 97
Table 14: World 11-Year Perspective for Contrast Media by
Product Segments - Percentage Breakdown of Dollar Sales for
X-Ray, MRI and Ultrasound Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 97
Table 15: World Recent Past, Current & Future Analysis for
X-Ray Contrast Media by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 98
Table 16: World Historic Review for X-ray Contrast Media by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 99
Table 17: World 11-Year Perspective for X-Ray Contrast Media
by Geographic Region- Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 100
Table 18: World Recent Past, Current & Future Analysis for MRI
Contrast Media by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 101
Table 19: World Historic Review for MRI Contrast Media by
Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 102
Table 20: World 11-Year Perspective for MRI Contrast Media by
Geographic Region- Percentage Breakdown of Dollar Sales for
US, Canada, Japan, Europe, Asia-Pacific (excluding Japan),
Middle East and Latin America Markets for Years 2005, 2010 &
2015 (includes corresponding Graph/Chart) 103
Table 21: World Recent Past, Current & Future Analysis for
Ultrasound Contrast Media by Geographic Region - US, Canada,
Japan, Europe, Asia-Pacific (excluding Japan), Middle East and
Latin America Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2007 through 2015 (includes
corresponding Graph/Chart) 104
Table 22: World Historic Review for Ultrasound Contrast Media
by Geographic Region - US, Canada, Japan, Europe, Asia-Pacific
(excluding Japan), Middle East and Latin American Markets
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 105
Table 23: World 11-Year Perspective for Ultrasound Contrast
Media by Geographic Region- Percentage Breakdown of Dollar
Sales for US, Canada, Japan, Europe, Asia-Pacific (excluding
Japan), Middle East and Latin America Markets for Years 2005,
2010 & 2015 (includes corresponding Graph/Chart) 106
Table 24: World Recent Past, Current & Future Analysis for
Diagnostic Radiopharmaceuticals by Geographic Region - US,
Canada, Japan, Europe, Asia-Pacific (excluding Japan), Middle
East and Latin America Markets Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2007 through
2015 (includes corresponding Graph/Chart) 107
Table 25: World Historic Review for Diagnostic
Radiopharmaceuticals by Geographic Region - US, Canada, Japan,
Europe, Asia-Pacific (excluding Japan), Middle East and Latin
American Markets Independently Analyzed with Annual Sales
Figures in US$ Million for Years 2000 through 2006 (includes
corresponding Graph/Chart) 108
Table 26: World 11-Year Perspective for Diagnostic
Radiopharmaceuticals by Geographic Region- Percentage
Breakdown of Dollar Sales for US, Canada, Japan, Europe,
Asia-Pacific (excluding Japan), Middle East and Latin America
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 109
15. THE UNITED STATES 110
A.Market Analysis 110
Outlook 110
Imaging Centers Feel the Heat During Recession 110
Growth Stimulants 111
Dynamics of Pricing 111
Diagnostic Radiopharmaceuticals 112
Market Scenario 112
Availability of Isotopes: A Tough Challenge 112
Radiopharmaceuticals to Drive Growth 112
Competitive Analysis - Imaging Market 113
Reimbursement Issues 113
Medicare 113
Magnetic Resonance Imaging 114
Regulatory Environment 115
Provisions Regarding Off-Label Usage of Contrast Media 116
Contrast Media 116
X-ray Contrast Media 116
MRI Contrast Media 116
Market Scenario 116
Managed Care Vs MRI Technology Diffusion 117
Ultrasound Contrast Media 117
B.Market Analytics 117
Table 27: US Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 117
Table 28: US Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2006 (includes corresponding Graph/Chart) 118
Table 29: US 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 119
16. CANADA 120
A.Market Analysis 120
Outlook 120
Diagnostic Equipment Market 120
LOCM Products Approved in Canada 120
B.Market Analytics 121
Table 30: Canadian Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment- Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 121
Table 31: Canadian Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 122
Table 32: Canadian 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 123
17. JAPAN 124
A.Market Analysis 124
Outlook 124
Reimbursement Issues 124
B.Market Analytics 125
Table 33: Japanese Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment - Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 125
Table 34: Japanese Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 126
Table 35: Japanese 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 127
18. EUROPE 128
A.Market Analysis 128
Outlook 128
Trends 128
Reimbursement 128
Outsourcing of Imaging Diagnostics 129
Distribution Structure 129
Direct Sales 129
License Agreements 129
Distribution Agreements 130
A Price Sensitive Market 130
Macro Environment 130
Germany 130
France 130
Spain & Italy 131
Scandinavia 131
B.Market Analytics 132
Table 36: European Recent Past, Current & Future Analysis
for Imaging Agents by Geographic Region - France, Germany,
UK, Italy, Spain, Russia and Rest of Europe Markets
Independently Analyzed with Annual Sales in US$ Million for
Years 2007 through 2015 (includes corresponding Graph/Chart) 132
Table 37: European Historic Review for Imaging Agents by
Geographic Region - France, Germany, UK, Italy, Spain,
Russia and Rest of Europe Markets Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 133
Table 38: European 11-Year Perspective for Imaging Agents by
Geographic Region - Percentage Breakdown of Dollar Sales for
France, Germany, UK, Italy, Spain, Russia and Rest of Europe
Markets for Years 2005, 2010 & 2015 (includes corresponding
Graph/Chart) 134
Table 39: European Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment - Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 135
Table 40: European Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 136
Table 41: European 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 137
18a.FRANCE 138
A.Market Analysis 138
Outlook 138
Growth Stimulants 138
B.Market Analytics 138
Table 42: French Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 138
Table 43: French Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 139
Table 44: French 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) & Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 140
18b.GERMANY 141
A.Market Analysis 141
Outlook 141
B.Market Analytics 141
Table 45: German Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 141
Table 46: German Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 142
Table 47: German 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 143
18c. ITALY 144
Market Analysis 144
Table 48: Italian Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 144
Table 49: Italian Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 145
Table 50: Italian 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 146
18d.THE UNITED KINGDOM 147
A.Market Analysis 147
Outlook 147
B.Market Analytics 147
Table 51: UK Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 147
Table 52: UK Historic Review for Imaging Agents by Product
Segment - Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Independently Analyzed with
Annual Sales Figures in US$ Million for Years 2000 through
2006 (includes corresponding Graph/Chart) 148
Table 53: UK 11-Year Perspective for Imaging Agents by
Product Segment Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 149
18e. SPAIN 150
Market Analysis 150
Table 54: Spanish Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment - Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 150
Table 55: Spanish Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 151
Table 56: Spanish 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 152
18f. RUSSIA 153
Market Analysis 153
Table 57: Russian Recent Past, Current & Future Analysis for
Imaging Agents by Product Segment -Contrast Media (X-ray,
MRI and Ultrasound) and Diagnostic Radiopharmaceuticals
Markets Independently Analyzed with Annual Sales in US$
Million for Years 2007 through 2015 (includes corresponding
Graph/Chart) 153
Table 58: Russian Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 154
Table 59: Russian 11-Year Perspective for Imaging Agents by
Product Segment - Percentage Breakdown of Dollar Sales for
Contrast Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets for Years 2005, 2010 & 2015
(includes corresponding Graph/Chart) 155
18g. REST OF EUROPE 156
Market Analysis 156
Table 60: Rest of Europe Recent Past, Current & Future
Analysis for Imaging Agents by Product Segment - Contrast
Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 156
Table 61: Rest of Europe Historic Review for Imaging Agents
by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 157
Table 62: Rest of Europe 11-Year Perspective for Imaging
Agents by Product Segment - Percentage Breakdown of Dollar
Sales for Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010
& 2015 (includes corresponding Graph/Chart) 158
19. ASIA-PACIFIC 159
A.Market Analysis 159
Outlook 159
MRI Market in Asia 159
ANSTO: Leading the Radiopharmaceuticals Market 159
India - A High Potential Market 159
B.Market Analytics 160
Table 63: Asia-Pacific Recent Past, Current & Future
Analysis for Imaging Agents by Product Segment - Contrast
Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 160
Table 64: Asia-Pacific Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 161
Table 65: Asia-Pacific 11-Year Perspective for Imaging
Agents by Product Segment - Percentage Breakdown of Dollar
Sales for Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010
& 2015 (includes corresponding Graph/Chart) 162
20. THE MIDDLE EAST 163
Market Analysis 163
Table 66: Middle East Recent Past, Current & Future Analysis
for Imaging Agents by Product Segment - Contrast Media
(X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 163
Table 67: Middle East Historic Review for Imaging Agents by
Product Segment - Contrast Media (X-ray, MRI and Ultrasound)
and Diagnostic Radiopharmaceuticals Independently Analyzed
with Annual Sales Figures in US$ Million for Years 2000
through 2006 (includes corresponding Graph/Chart) 164
Table 68: Middle East 11-Year Perspective for Imaging Agents
by Product Segment - Percentage Breakdown of Dollar Sales
for Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010
& 2015 (includes corresponding Graph/Chart) 165
21. LATIN AMERICA 166
A.Market Analysis 166
Private Sector Boosts Healthcare Segment 166
B.Market Analytics 166
Table 69: Latin American Recent Past, Current & Future
Analysis for Imaging Agents by Product Segment - Contrast
Media (X-ray, MRI and Ultrasound) and Diagnostic
Radiopharmaceuticals Markets Independently Analyzed with
Annual Sales in US$ Million for Years 2007 through 2015
(includes corresponding Graph/Chart) 166
Table 70: Latin American Historic Review for Imaging Agents
by Product Segment - Contrast Media (X-ray, MRI and
Ultrasound) and Diagnostic Radiopharmaceuticals
Independently Analyzed with Annual Sales Figures in US$
Million for Years 2000 through 2006 (includes corresponding
Graph/Chart) 167
Table 71: Latin American 11-Year Perspective for Imaging
Agents by Product Segment - Percentage Breakdown of Dollar
Sales for Contrast Media (X-ray, MRI and Ultrasound) and
Diagnostic Radiopharmaceuticals Markets for Years 2005, 2010
& 2015 (includes corresponding Graph/Chart) 168
COMPETITIVE LANDSCAPE
Total Companies Profiled: 55 (including Divisions/Subsidiaries - 71)
------------------------------------------
Region/Country Players
------------------------------------------
The United States 37
Canada 3
Japan 6
Europe 19
France 2
Germany 6
The United Kingdom 3
Italy 2
Rest of Europe 6
Asia-Pacific (Excluding Japan) 5
Africa 1
------------------------------------------
To order this report:
: Global Imaging Agents Industry
Check our Company Profile, SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article